On December 18, 2024, the Science and Technology Bureau of Wuxi City released the “Public Notice of the List of Enterprises Proposed for Inclusion in the 2024 Wuxi City Young Eagle Enterprise Cultivation Program”, and Clairvo Technology was successfully included. As a high-growth technology enterprise that is a key focus of cultivation in Wuxi City, “Chuying Enterprise” symbolizes start-up and growth-stage enterprises with core technologies, broad market prospects and outstanding innovation capabilities. This inclusion in the database marks that Clairvo Technology has officially entered the key support system of Wuxi City’s scientific and technological innovation echelon.

Since its establishment, it has been deeply engaged in optical coherence tomography (OCT) technology. It has achieved multiple key breakthroughs in the fields of precise ophthalmic diagnosis and treatment and industrial non-destructive testing. Its core products have complete independent intellectual property rights, and their performance indicators have reached the international advanced level.

Being selected into the “Young Eagle Enterprise” cultivation pool this time means that Clairvo Technology will receive continuous policy support from the government in terms of R&D funding, financial support, talent introduction, and industrial connection, providing strong impetus for the company’s next stage of technological upgrading and market expansion. In the future, Clairvo Technology will rely on the favorable innovation and entrepreneurship ecosystem in Wuxi City, continue to focus on the high-end medical imaging and industrial inspection fields, and contribute “Clairvo” strength to the independent control of China’s high-end medical equipment.